Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Phase 2 Study of ACP-196 in Subjects With Mantle Cell Lymphoma

NCT02213926 is registered in ClinicalTrials.gov with Acerta Pharma BV as lead sponsor.

NCT NCT02213926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02213926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Phase 2 Study of ACP-196 in Subjects With Mantle Cell Lymphoma
Lead sponsor
Acerta Pharma BV
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 2, 2015
Completion date
September 6, 2026
Enrollment
124 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

mantle cell lymphoma (mcl)